Leading to competitiveness through innovation in medical devices, biomaterials, and processes.

RESCOLL participated in the round table discussion titled “The resources of 3D printing”

3D day 3DRESCOLL was present April 16th, 2015 at “usine IO” in Paris for a day of meetings and debates between industry and implementors of 3D printing organized by the “Fédération de la Plasturgie et des Composites” (French Federation of Plastics and Composites)

The day was punctuated by a series of round tables including specialists who came to debate and discuss their experiences for: Deciphering the changes and challenges of an emerging industry (including machine manufacturers, material suppliers, industrial uses and expectations); Discovering new uses for 3D printing and the prospects they open; Understanding the 3D printing future across research areas (technology, materials and modeling); Identifying new models associated with 3D printing (manufacture agility, collaborative and digital revolution) and their main impact on the industry.

Elodie PACARD, our specialist in medical devices, participated in the round table discussion titled “The resources of 3D printing” to assess the impacts and opportunities of 3D printing and present potential new uses and the main prospects 3D printing will open in the healthcare sector. Today’s 3D printing is becoming increasingly important in this area. It is mainly used for manufacturing customized medical devices (surgical implants & guides), for producing 3D models to evaluate the better surgical approaches, and for manufacturing complex matrix used in Tissue Engineering (Scaffold). However it can also be used for manufacturing organ ” Bio-printing “, this innovative manufacturing technology raises many questions in a highly regulated field (Directives 93/42 / EEC, Directive 2004/23 / EEC, Directive 1394/2007, the code of public health … etc)

This day was dedicated to assessing and debating the aspects of 3D printing that allow industry and implementors to identify the impacts and opportunities of 3D printing on their businesses.

Moreover, it was an opportunity for RESCOLL to resubmit its 3D printing platform dedicated to polymers and composites, the “MED FAB LAB”, to design medical devices in an ISO 13485 environment and also to qualify through our accredited testing laboratory and IS0 17025 Mechanical tests:

  • Design of devices: Transforming the idea, imaging in CAD model.
  • Printing: Manufacture High-resolution model (up to 30 microns)
  • Implementation: Manufacture materials for 3D printing (composite, containing active product, polymers not reachable to 3D printing etc …).
  • Validation: Morphology, chemical, physicochemical, Mechanics etc …


Link to the program: http://www.laplasturgie.fr/le-3d-day-160415-usine-io-paris/